Business
Shareholder Approval
Shareholder Approval.
About this update from Seeing Machines Limited
[{"type":"text","content":"\n Seeing Machines Limited\n26 October 2007\n\n\n \n26 October 2007\n\n\n Seeing Machines Limited\n\n ('Seeing Machines' or the 'Company')\n\n\n Share Holder Approval for Share Issue\n\n\nFurther to the announcements on 24 and 25 September 2007, Seeing Machines (AIM:\nSEE), a leading developer of advanced computer based imaging software systems,\nis pleased to announce that the General Meeting held today 26 October has\napproved the issue of shares to satisfy the combined placings. Completion of the\nfund raising is now only subject to the shares being admitted for trading on AIM\nwhich is expected to occur on 30 October 2007.\n\n\n--- ENDS ---\n\n\n\nEnquiries:\n\nSeeing Machines Limited Insinger de Beaufort Parkgreen Communications\nNick Cerneaz, CEO Peter Ward, Chris Caldwell Ben Knowles, Erica Nelson\n+61 (0) 2 6125 6501 +44 (0) 20 7190 7015 +44 (0) 20 7851 7480\nwww.seeingmachines.com\n\n\nNotes to editors:\n\n\nAbout Seeing Machines\n\n\nSeeing Machines is an award winning Technology Company which focuses on vision\nbased human machine interfaces. Formed in 2000 in Canberra, Australia, Seeing\nMachines' purpose is to commercialise its computer-vision across a range of\nindustries and applications.\n\nSeeing Machines deliver advanced computer vision solutions for researches and\ndevelopers in human factors, transportation safety, computer human interaction,\nrobotics, medical research and psychology. The flagship product faceLAB(R)\nprovides an automated and contact-free gaze and head tracking technology, it\nsolves the problem of observing human behaviour naturally, non-intrusively and\nwith a high degree of accuracy and usability. Building on these unique face\ntracking and pupil measurement and monitoring capabilities, the TrueField\nAnalyzer(R) is new medical device to assist clinicians detect and manage eye\ndiseases such as glaucoma.\n\nThe TrueField Analyzer(R) offers a new objective method to help doctors diagnose\nand manage a range of eye diseases including glaucoma, age related macular\ndegeneration and diabetic retinopathy. Glaucoma affects about 2-3% of the\npopulation over 40 years of age and is a leading source of blindness. Unlike\nmost other devices available to the clinician the TrueField Analyzer is a\ncompletely objective test and it is quick and easy for patients and technicians\nalike. The device measu...